The bacterium Clostridioides difficile is named “difficult” for a reason. Originally it was hard to grow in the lab, and now ...

C. difficile spores are highly resistant to desiccation, chemicals and extreme temperature. Spores frequently contaminate the environment around patients with CDI, potentially persisting for ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.

Administration of antibiotics for C. difficile has unintended consequences and can create a vicious cycle of infection treatment, disruption of the healthy biome and a 25% increase in the risk of ...

Scientists have gained fresh insights into the prevention of the superbug Clostridium difficile (C. difficile) thanks to a new study. C. difficile is found in the environment but is most common in ...

diff gets recurrent C. diff," says Dr. Allegretti. "It has a lot to do with your host response, your gut microbiome, and your individual risk factors, such as immunosuppression or inflammatory bowel ...

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

In fact, C. diff infections often spring up because the bacteria take advantage of a weakened microbiome following treatment with antibiotics for other diseases. “Treatment of C. difficile ...

When those bacteria die — for instance, as a result of antibiotic treatment for an unrelated infection — the large intestine ...

Against that backdrop, the shortlisting of Astellas Pharma's C. diff treatment Dificlir (fidaxomicin) for the UK Prix Galien Innovative Product Award, reflects the critical need for additional ...